Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Armodafinil for Fatigue in Patients on Taxane Chemotherapy
NCT00825227Phase 2Terminated
- Sponsor
- Cephalon, Inc.
- Start
- Dec 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of armodafinil in cancer-related fatigue (CRF), sponsored by Cephalon, Inc.. Started Dec 2008; status: terminated.
02
Drugs
armodafinil
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT00825227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00825227.